Financials

  • Market Capitalization 70.88 M
  • Employee 6
  • Founded 2000
  • CEO Yuichi Iwaki
  • Website www.medicinova.com
  • Headquarter Delaware, United States
  • FIGI BBG000RDP030
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.46
Rapporto prezzo/fatturato
156.89

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4104
ANVS
Annovis Bio, Inc. Common Stock
1.72 USD-4.97%-6.01%-2.27%-25.54%73.28 M USD
4107
CRDF
Cardiff Oncology, Inc. - Common Stock
0.94 USD-5.05%+1.08%+18.99%-54.81%73.13 M USD
4123
SPRO
Spero Therapeutics, Inc. - Common Stock
1.20 USD-0.83%-1.64%0.00%-41.18%69.88 M USD
4125
XBIT
XBiotech Inc. - Common Stock
2.27 USD-1.30%-0.44%+0.89%-27.94%69.21 M USD

Notizie